Keyword: Vertex Pharmaceuticals
News
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
News
02.11.2012
- Vertex Pharmaceuticals reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company turned its...
News
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
News
05.04.2012
- A raft of new medicines pushed U.S. spending on drugs modestly higher last year, but the gains were curbed by weak prescription use as Americans avoided doctor visits, according to...
